These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

683 related articles for article (PubMed ID: 30912920)

  • 1. Surface-Functionalized Modified Copper Sulfide Nanoparticles Enhance Checkpoint Blockade Tumor Immunotherapy by Photothermal Therapy and Antigen Capturing.
    Wang R; He Z; Cai P; Zhao Y; Gao L; Yang W; Zhao Y; Gao X; Gao F
    ACS Appl Mater Interfaces; 2019 Apr; 11(15):13964-13972. PubMed ID: 30912920
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Light-triggered OVA release based on CuS@poly(lactide-co-glycolide acid) nanoparticles for synergistic photothermal-immunotherapy of tumor.
    Chen Z; Zhang Q; Zeng L; Zhang J; Liu Z; Zhang M; Zhang X; Xu H; Song H; Tao C
    Pharmacol Res; 2020 Aug; 158():104902. PubMed ID: 32417504
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multifunctional nanoparticles precisely reprogram the tumor microenvironment and potentiate antitumor immunotherapy after near-infrared-II light-mediated photothermal therapy.
    Ge Y; Zhang J; Jin K; Ye Z; Wang W; Zhou Z; Ye J
    Acta Biomater; 2023 Sep; 167():551-563. PubMed ID: 37302731
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Photothermally activatable PDA immune nanomedicine combined with PD-L1 checkpoint blockade for antimetastatic cancer photoimmunotherapy.
    Lu Q; Qi S; Li P; Yang L; Yang S; Wang Y; Cheng Y; Song Y; Wang S; Tan F; Li N
    J Mater Chem B; 2019 Apr; 7(15):2499-2511. PubMed ID: 32255127
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nanoscale Reduced Graphene Oxide-Mediated Photothermal Therapy Together with IDO Inhibition and PD-L1 Blockade Synergistically Promote Antitumor Immunity.
    Yan M; Liu Y; Zhu X; Wang X; Liu L; Sun H; Wang C; Kong D; Ma G
    ACS Appl Mater Interfaces; 2019 Jan; 11(2):1876-1885. PubMed ID: 30582788
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Single agent nanoparticle for radiotherapy and radio-photothermal therapy in anaplastic thyroid cancer.
    Zhou M; Chen Y; Adachi M; Wen X; Erwin B; Mawlawi O; Lai SY; Li C
    Biomaterials; 2015 Jul; 57():41-9. PubMed ID: 25913249
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Copper sulfide nanoparticles with phospholipid-PEG coating for in vivo near-infrared photothermal cancer therapy.
    Huang Y; Lai Y; Shi S; Hao S; Wei J; Chen X
    Chem Asian J; 2015 Feb; 10(2):370-6. PubMed ID: 25425287
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immune Checkpoint Blockade Mediated by a Small-Molecule Nanoinhibitor Targeting the PD-1/PD-L1 Pathway Synergizes with Photodynamic Therapy to Elicit Antitumor Immunity and Antimetastatic Effects on Breast Cancer.
    Zhang R; Zhu Z; Lv H; Li F; Sun S; Li J; Lee CS
    Small; 2019 Dec; 15(49):e1903881. PubMed ID: 31702880
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Functionalized biomimetic nanoparticles combining programmed death-1/programmed death-ligand 1 blockade with photothermal ablation for enhanced colorectal cancer immunotherapy.
    Xiao Y; Zhu T; Zeng Q; Tan Q; Jiang G; Huang X
    Acta Biomater; 2023 Feb; 157():451-466. PubMed ID: 36442821
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ataxia telangiectasia mutated inhibitor-loaded copper sulfide nanoparticles for low-temperature photothermal therapy of hepatocellular carcinoma.
    Cai H; Dai X; Guo X; Zhang L; Cao K; Yan F; Ji B; Liu Y
    Acta Biomater; 2021 Jun; 127():276-286. PubMed ID: 33812073
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multifunctional PEG-GO/CuS nanocomposites for near-infrared chemo-photothermal therapy.
    Bai J; Liu Y; Jiang X
    Biomaterials; 2014 Jul; 35(22):5805-13. PubMed ID: 24767788
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antifouling Dendrimer-Entrapped Copper Sulfide Nanoparticles Enable Photoacoustic Imaging-Guided Targeted Combination Therapy of Tumors and Tumor Metastasis.
    Ouyang Z; Li D; Xiong Z; Song C; Gao Y; Liu R; Shen M; Shi X
    ACS Appl Mater Interfaces; 2021 Feb; 13(5):6069-6080. PubMed ID: 33501834
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tumor-targeting CuS nanoparticles for multimodal imaging and guided photothermal therapy of lymph node metastasis.
    Shi H; Yan R; Wu L; Sun Y; Liu S; Zhou Z; He J; Ye D
    Acta Biomater; 2018 May; 72():256-265. PubMed ID: 29588255
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Light-Responsive Core-Shell Nanoplatform for Bimodal Imaging-Guided Photothermal Therapy-Primed Cancer Immunotherapy.
    Zhang W; Zhang CC; Wang XY; Li L; Chen QQ; Liu WW; Cao Y; Ran HT
    ACS Appl Mater Interfaces; 2020 Oct; 12(43):48420-48431. PubMed ID: 33073973
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cetuximab-modified CuS nanoparticles integrating near-infrared-II-responsive photothermal therapy and anti-vessel treatment.
    Li B; Jiang Z; Xie D; Wang Y; Lao X
    Int J Nanomedicine; 2018; 13():7289-7302. PubMed ID: 30510418
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PEGylated reduced-graphene oxide hybridized with Fe
    Wang L; Wang M; Zhou B; Zhou F; Murray C; Towner RA; Smith N; Saunders D; Xie G; Chen WR
    J Mater Chem B; 2019 Dec; 7(46):7406-7414. PubMed ID: 31710067
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tailor-made PEG-DA-CuS nanoparticles enriched in tumor with the aid of retro Diels-Alder reaction triggered by their intrinsic photothermal property.
    Sheng J; Ma B; Yang Q; Zhang C; Jiang Z; Borrathybay E
    Int J Nanomedicine; 2018; 13():4291-4302. PubMed ID: 30087561
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of a nanocomposite of PEG-curcumin-gold nanoparticles as a near-infrared photothermal agent: an in vitro and animal model investigation.
    Rahimi-Moghaddam F; Azarpira N; Sattarahmady N
    Lasers Med Sci; 2018 Nov; 33(8):1769-1779. PubMed ID: 29790012
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synergistic photothermal cancer immunotherapy by Cas9 ribonucleoprotein-based copper sulfide nanotherapeutic platform targeting PTPN2.
    Yan T; Yang K; Chen C; Zhou Z; Shen P; Jia Y; Xue Y; Zhang Z; Shen X; Han X
    Biomaterials; 2021 Dec; 279():121233. PubMed ID: 34749073
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rationally designed peptide-conjugated gold/platinum nanosystem with active tumor-targeting for enhancing tumor photothermal-immunotherapy.
    Yang Q; Peng J; Shi K; Xiao Y; Liu Q; Han R; Wei X; Qian Z
    J Control Release; 2019 Aug; 308():29-43. PubMed ID: 31252039
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 35.